B. Brett Finlay
Academic Advisor

B. Brett Finlay


The Peter Wall Distinguished Professor of the University of British Colombia. Recipient of several awards including the E.W.R. Steacie Prize, the CSM Fisher Scientific Award, an MRC Scientist, five Howard Hughes International Research Scholar Awards, a CIHR Distinguished Investigator, BC Biotech Innovation Award, the Michael Smith Health Research Prize, the IDSA Squibb award, the Jacob Biely Prize. Cofounder of Inimex Pharmaceuticals, Inc., and Director of the SARS Accelerated Vaccine Initiative

Biochemistry Infectious Diseases Microbiology

Work details

Peter Wall Distinguished Professor

University of British Colombia
Departments of Biochemistry and Molecular Biology, and Microbiology and Immunology
Finlay’s lab is based in Vancouver, British Columbia, Canada in the Michael Smith Laboratories at the University of British Columbia, and involves a multidisciplinary research program exploring how microbes contribute to both human health and disease. The lab specifically focuses on type III secreted virulence factors from Salmonella and pathogenic E. coli, how microbiota influence infectious diarrhea outcomes, and the role of the microbiota in asthma, malnutrition, and environmental enteropathy.

PeerJ Contributions